Wockhardt Ltd (WCKH.NS)
|Market Cap (Mil.):||Rs43,401.09|
|Shares Outstanding (Mil.):||109.75|
MUMBAI - Wockhardt Ltd faces a sharp drop in market share and delays in new launch approvals after a second plant operated by the generic drugmaker was hit by the U.S. Food and Drug Administration's "import alert", effectively a ban.
* Chikalthana plant had US sales of $230 mln last fiscal year
MUMBAI, Nov 27 - The U.S. Food and Drug Administration has imposed an "import alert", effectively a ban, on the Chikalthana plant operated by Indian generic drugmaker Wockhardt Ltd, the regulator said in a notice on its website, sending the company's shares down as much as 13.5 percent.
* Manappuram Finance Ltd shares gain 4.8 percent, Muthoot Finance Ltd surges 10 percent, Wockhardt Ltd is up 6 percent, while Indiabulls Securities Ltd rises 4 percent after the National Stock Exchange increases their daily price limits. * Daily limits in these companies have been raised to 20 percent from 5 percent, the NSE said late on Wednesday. * The exchange periodically adjusts the daily limits for companies' shares based on a set of criteria such as liquidity. (swati.bhat@thomsonreut
MUMBAI - Wockhardt Ltd faces a year or more to get U.S. and British regulators to end curbs on its shipments of medicines to the two countries, the Indian drugmaker said on Friday after posting its smallest profit in six quarters.
* Exec says may take over 1 year to resolve regulatory issues
MUMBAI, Oct 25 - India's Wockhardt Ltd posted its smallest profit in six quarters, hurt by curbs on shipping medicines to the United States and Britain from one of its factories after their health regulators identified deficiencies at the plant.
Oct 22 - Britain's drug regulator revoked the quality compliance certificate for a Wockhardt Ltd factory in India, the drugmaker said on Tuesday, the third of its plants to be hit by export restrictions this year.
- Britain's Medicines and Healthcare products Regulatory Agency has recalled five prescription-only drugs made by India's Wockhardt Ltd after it found deficiencies in manufacturing procedures at the drugmaker's Chikalthana factory.
MUMBAI - Britain's drug authorities have revoked their approval for one of Wockhardt Ltd's key plants - a fresh regulatory rebuke that sent shares in the Indian drugmaker tumbling and underscores the long road it faces in restoring its reputation.